Rosenstock, J., Franco, D., Korpachev, V., Shumel, B., Ma, Y., Baughman, R., . . . McGill, J. B. (2015). Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents. Diabetes care, 38(12), 2274-2281. https://doi.org/10.2337/dc15-0629
Chicago Style (17th ed.) CitationRosenstock, Julio, Denise Franco, Vadym Korpachev, Brad Shumel, Yuhui Ma, Robert Baughman, Nikhil Amin, and Janet B. McGill. "Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents." Diabetes Care 38, no. 12 (2015): 2274-2281. https://doi.org/10.2337/dc15-0629.
MLA (9th ed.) CitationRosenstock, Julio, et al. "Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents." Diabetes Care, vol. 38, no. 12, 2015, pp. 2274-2281, https://doi.org/10.2337/dc15-0629.